Potassium Chloride NDC 70771-1600

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1600Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1600Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1600-0	70771160000	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1600-0)Marketed from Feb 3, 2022
70771-1600-1	70771160001	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1600-1)Marketed from Feb 3, 2022
70771-1600-5	70771160005	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1600-5)Marketed from Feb 3, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 1500 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210395
Marketing start: Feb 3, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 70771-1600_c6b38e40-cd5a-41ed-92d6-eb25e9c0c725SPL ID c6b38e40-cd5a-41ed-92d6-eb25e9c0c725SPL set ID 099c3a36-f460-4191-80e5-0c4153a5c713RxCUI 1801294, 1801298UNII 660YQ98I10UPC 0370771160013, 0370771159918

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771160000 followed by a unit qualifier and the quantity

Package 70771-1600-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 18, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH CONTROLLED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210395

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210395
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 750 mg/1	Tablet, Extended releaseOral	Zydus Lifesciences Limited	70771-1599
Potassium Chloride	Potassium chloride 1500 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-740
Potassium Chloride	Potassium chloride 750 mg/1	Tablet, Extended releaseOral	Zydus Pharmaceuticals (USA) Inc.	68382-861